+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Proteasome Inhibitors Market Report 2026 - Product Thumbnail Image

Proteasome Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Soft Tissue Sarcoma Market Report 2026 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Myostatin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Myostatin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Polymyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Polymyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Heart Failure - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Heart Failure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Scientific Research and Development Services Market Report 2026 - Product Thumbnail Image

Scientific Research and Development Services Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Angina Pectoris- Pipeline Insight, 2025 - Product Thumbnail Image

Angina Pectoris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Venous Thromboembolism - Pipeline Insight, 2025 - Product Thumbnail Image

Venous Thromboembolism - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Beta Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
CTLA-4 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

CTLA-4 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 220 Pages
  • Global
From
TIGIT Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

TIGIT Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 100 Pages
  • Global
From
CAR T - Cell Therapy - Competitive Landscape, 2026 - Product Thumbnail Image

CAR T - Cell Therapy - Competitive Landscape, 2026

  • Report
  • January 2026
  • 500 Pages
  • Global
From
Checkpoint Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
From
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
  • Global
From
Loading Indicator